Jumo Health Partners with Areti Health to Power AI-Driven Trial Readiness Platform

Jumo Health, a Patient Experience Organization, today announced a strategic partnership with Areti Health, an AI technology company, to advance the innovation and execution of PRISM™, Jumo Health's readiness-based clinical trial recruitment, enrollment, and retention system.

PRISM was created to address a persistent challenge in clinical research: while sponsors and CROs have become increasingly effective at identifying medically eligible patients, many trials continue to struggle once participation begins. Screen failure after consent, early dropout, protocol deviations, site escalation, and costly rescue recruitment remain common, largely because patients enter trials before they are fully prepared for the emotional, cognitive, and practical demands of participation. The partnership with Areti Health strengthens PRISM's ability to treat readiness as a governed, measurable execution variable rather than an assumption, allowing readiness to be operationalized consistently and at scale across complex trial environments.

"Bringing PRISM to market at scale requires more than AI in name, it requires a partner that understands how conversational, generative, and agentic AI must operate inside regulated, high-stakes clinical trial environments," said Brittany Erana, Chief Executive Officer of Jumo Health. "Areti Health is a leader in this space, not because they apply AI broadly, but because they've built the delivery mechanisms required to support real decision-making, governed interactions, and sustained execution. This partnership allows Jumo Health to continue innovating PRISM as a readiness-based system that is both operationally rigorous and built for real-world trial complexity."